ANIK stock forecast
Our latest prediction for Anika Therapeutics, Inc.'s stock price was made on the Feb. 28, 2019 when the stock price was at 32.63$.
In the short term (2weeks), ANIK's stock price should outperform the market by 2.86%. During that period the price should oscillate between -5.93% and +8.39%.
In the medium term (3months), ANIK's stock price should outperform the market by 2.76%. During that period the price should oscillate between -14.08% and +20.20%.Get email alerts
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.
At the moment the company generates 106M USD in revenues.
On its last earning announcement, the company reported a profit of 1.27$ per share.
The book value per share is 16.91$
Three months stock forecastFeb. 28, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|